Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Gundert-Remy

Showing results (11-20 of 267) with videos related to

Pageof 27
Sort By:
Toxicology Letters|December 25, 2012
Commentary: dermal penetration of bisphenol A--consequences for risk assessmentUrsula Gundert-Remy, Hans Mielke, Ulrike Bernauer
Archives of Toxicology|March 13, 2010
Chronic oral LOAEL prediction by using a commercially available computational QSAR toolBernd Rupp, Klaus E Appel, Ursula Gundert-Remy
Toxicology Letters|October 15, 2017
Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkersGisela H Degen, Nurshad Ali, Ursula Gundert-Remy
Pharmaceutics|April 28, 2023
Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of DataEngi Abdelhady Algharably, Reinhold Kreutz, Ursula Gundert-Remy
Toxicology|August 2, 2005
Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scalingHans Mielke, Anna Gundert, Klaus Abraham, et al.
Deutsches Arzteblatt International|March 20, 2012
New drugs: evidence relating to their therapeutic value after introduction to the marketMariam Ujeyl, Claudia Schlegel, Siegbert Walter, et al.
Archives of Toxicology|January 4, 2019
Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)Engi Abdel Hady Algharably, Reinhold Kreutz, Ursula Gundert-Remy
Frontiers in Pharmacology|February 7, 2019
Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-FeedingEstella Dora Germaine Garessus, Hans Mielke, Ursula Gundert-Remy
Basic & Clinical Pharmacology & Toxicology|March 6, 2018
Exposure of Nursed Infants to Maternal Treatment with Ethambutol and RifampicinFalko Partosch, Hans Mielke, Ralf Stahlmann, et al.
Archives of Toxicology|November 27, 2004
Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and durationKlaus Abraham, Hans Mielke, Wilhelm Huisinga, et al.
Pageof 27

Showing results (11-20 of 267) with videos related to

Sort By:
Pageof 27
Toxicology Letters|December 25, 2012
Commentary: dermal penetration of bisphenol A--consequences for risk assessmentUrsula Gundert-Remy, Hans Mielke, Ulrike Bernauer
Archives of Toxicology|March 13, 2010
Chronic oral LOAEL prediction by using a commercially available computational QSAR toolBernd Rupp, Klaus E Appel, Ursula Gundert-Remy
Toxicology Letters|October 15, 2017
Preliminary data on citrinin kinetics in humans and their use to estimate citrinin exposure based on biomarkersGisela H Degen, Nurshad Ali, Ursula Gundert-Remy
Pharmaceutics|April 28, 2023
Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of DataEngi Abdelhady Algharably, Reinhold Kreutz, Ursula Gundert-Remy
Toxicology|August 2, 2005
Acute inhalative exposure assessment: derivation of guideline levels with special regard to sensitive subpopulations and time scalingHans Mielke, Anna Gundert, Klaus Abraham, et al.
Deutsches Arzteblatt International|March 20, 2012
New drugs: evidence relating to their therapeutic value after introduction to the marketMariam Ujeyl, Claudia Schlegel, Siegbert Walter, et al.
Archives of Toxicology|January 4, 2019
Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)Engi Abdel Hady Algharably, Reinhold Kreutz, Ursula Gundert-Remy
Frontiers in Pharmacology|February 7, 2019
Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-FeedingEstella Dora Germaine Garessus, Hans Mielke, Ursula Gundert-Remy
Basic & Clinical Pharmacology & Toxicology|March 6, 2018
Exposure of Nursed Infants to Maternal Treatment with Ethambutol and RifampicinFalko Partosch, Hans Mielke, Ralf Stahlmann, et al.
Archives of Toxicology|November 27, 2004
Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and durationKlaus Abraham, Hans Mielke, Wilhelm Huisinga, et al.
Pageof 27